glp-1 kidney receptor agonists and next-generation metabolic hormone therapies in chronic disease SGLT2 Inhibitors and GLP-1 Receptor

In summary, different GLP-1RAs improve skeletal muscle atrophy through multiple molecular mechanisms, involving multiple pathways such as insulin resistance regulation, inflammation suppression, and mitochondrial function improvement (see Table 1), providing a theoretical basis for the clinical treatment of sarcopenia with GLP-1RAs

Glucose-dependent insulinotropic polypeptide (GIP) inhibits bone resorption independently of insulin and glycemia

They found an increased risk of DVTs for people taking GLP-1 drugs

These mold spores float through the air and spread

Studies have found that such a high dose could affect liver function

Week 5 reassessment: Check inflammatory markers (CRP, ESR, relevant condition-specific markers)